Prevention and treatment of infectious and inflammatory complications in gynecological patients in the postoperative period

Introduction. Currently, there is a high frequency of vaginal microbiocenosis disorders (85–90%) in the postoperative period in patients with various nosological forms of gynecological diseases requiring surgical treatment.

Aim. To study the efficacy and tolerability of Depantol®, a combination of an antiseptic and a reparant complex, for the prevention and treatment of postoperative infectious and inflammatory complications of the lower genital tract after surgical interventions performed through vaginal access.

Materials and methods. A prospective comparative study involving 588 patients who underwent vaginal surgery was designed to evaluate the efficacy of Depantol® in the prevention and treatment of infectious and inflammatory complications of the lower genital tract. The first group consisted of 98 patients who underwent vaginal hysterectomy, vaginal wall plastic surgery and/or transsacrospinal hysteropexy and standard postoperative management; the second group consisted of 236 patients who underwent vaginal hysterectomy and vaginal wall plastic surgery; in addition to standard therapy for 10 days, the patients received Depantol® 1 suppository 2 times a day for 10 days; the third – 254 patients after transsacrospinal hysteropexy, who received Depantol in the postoperative period, according to the instructions for use.

Results. The results of the study demonstrated that clinical symptoms 14 days after treatment were observed in 49.9% of patients in the first group, 2.1% in the second, and 1.5% in the third, which may indicate a favorable effect of Depantol on the processes of trophism and regeneration of vaginal tissues, which is confirmed by 25% (OR 0.3 (CI: 0.11–0.71, p < 0.05), RR 0.25 (CI: 0.14–0.46, p < 0.05)) less pronounced hyperemia of the postoperative wound in patients of the second and third groups than in patients of the first group.

Conclusions. The long-term results of the study allow us to recommend Depantol, with high compliance, good tolerability, a favorable safety profile, corresponding to the principles of FTS-active management of the postoperative period in patients after vaginal surgeries, in order to accelerate recovery by optimizing rehabilitation, reducing microbial contamination of the vagina, and enhancing the epithelialization processes of the postoperative wound.

1. Noé G.K. Genital prolapse surgery: what options do we have in the age of mesh issues? J Clin Med. 2021;10(2):267. https://doi.org/10.3390/jcm10020267.

2. Беженарь ВФ, Линде ВА, Плеханов АН (ред.). Влагалищный доступ в гинекологии. М.: ГЭОТАР-Медиа; 2024. 200 с. https://doi.org/10.33029/9704-8150-9-VIG-2024-1-200.

3. Maher C, Yeung E, Haya N, Christmann-Schmid C, Mowat A, Chen Z et al. Surgery for women with apical vaginal prolapse. Cochrane Database Syst Rev. 2023;7(7):CD012376. https://doi.org/10.1002/14651858.CD012376.pub2.

4. Lapina IA, Dobrokhotova YE, Taranov VV, Chirvon TG, Volkova P, Malakhova AA. Comprehensive management of patients with pelvis organ prolapse and metabolic syndrome. Gynecology. 2021;23(3):260–266. (In Russ.) https://doi.org/10.26442/20795696.2021.3.200962.

5. Balgobin S, Balk EM, Porter AE, Misal M, Grisales T, Meriwether KV et al.; Society of Gynecologic Surgeons Systematic Review Group. Enabling Technologies for Gynecologic Vaginal Surgery: A Systematic Review. Obstet Gynecol. 2024;143(4):524–537. https://doi.org/10.1097/AOG.0000000000005522.

6. Lowenstein L, Mor O, Matanes E, Justman N, Stuart A, Baekelandt J. Conventional vaginal approach vs. transvaginal natural orifice transluminal endoscopic surgery for treating apical prolapse, a randomized controlled study. Eur J Obstet Gynecol Reprod Biol. 2024;303:180–185. https://doi.org/10.1016/j.ejogrb.2024.10.032.

7. Miranne JM, Gabriel I, Cohen SL, Abdalian T, Ajao MO, Minassian VA. Oxycodone Use During the Postoperative Period After Hysterectomy for Benign Indications. Female Pelvic Med Reconstr Surg. 2022;28(2):90–95. https://doi.org/10.1097/SPV.0000000000001084.

8. Khudoley EP, Ishchenko AI, Aleksandrov LS, Ishchenko AA. Application of the fast track principles of surgery in the treatment of a paz prolapse. V.F. Snegirev Archives of Obstetrics and Gynecology. 2019;6(2):98–102. (In Russ.) https://doi.org/10.18821/2313-8726-2019-6-2-98-102.

9. Volkov OA, Shramko SV, Marchenko EE, Karapetyan AJ, Vlasenko AE. The impact of Fast Track Surgery technology on the outcomes of laparoscopic non-hysterectomy interventions. Akusherstvo i Ginekologiya (Russian Federation). 2024;(9):99–107. (In Russ.) https://doi.org/10.18565/aig.2024.155.

10. Dobrokhotova YuE, Lapina IA, Tyan AG, Taranov VV, Chirvon TG, Glebov NV, Kaykova OV. Prevention of infectious complications after genital prolapse surgery. Akusherstvo i Ginekologiya (Russian Federation). 2024;(4):139–146. (In Russ.) https://doi.org/10.18565/aig.2024.70.

11. Nowakowski Ł, Gałczyński K, Dybowski M, Typek R, Dawidowicz A, Miotła P, Olcha P, Rechberger T. Effects of topical dehydroepiandrosterone therapy in women after pelvic organ prolapse surgery. Menopause. 2023;30(6):629–634. https://doi.org/10.1097/GME.0000000000002183.

12. Søgaard NB, Glavind K. Complications and re-operations after tension-free vaginal tape operation in women with stress urinary incontinence. Int Urogynecol J. 2021;32(1):159–166. https://doi.org/10.1007/s00192-020-04402-5.

13. Lundmark Drca A, Alexandridis V, Andrada Hamer M, Teleman P, Söderberg MW, Ek M. Dyspareunia and pelvic pain: comparison of midurethral sling methods 10 years after insertion. Int Urogynecol J. 2024;35(1):43–50. https://doi.org/10.1007/s00192-023-05585-3.

14. Daly JO, Frazer M, Cartwright R, Veit-Rubin N, Giles M. The role of microbial colonisation and infection in pelvic floor mesh complications and implications for management: a commentary. BJOG. 2020;127(2):260–263. https://doi.org/10.1111/1471-0528.15965.

15. Manukhin IB, Manukhina EI, Safaryan IR. Vaginal hygiene to prevent postoperative complications in various gynecological diseases. Russian Journal of Woman and Child Health. 2021;4(4):322–327. (In Russ.) https://doi.org/10.32364/2618-8430-2021-4-4-322-327.

16. Ciarolla AA, Lapin N, Williams D, Chopra R, Greenberg DE. Physical approaches to prevent and treat bacterial biofilm. Antibiotics. 2022;12(1):54. https://doi.org/10.3390/antibiotics12010054.

17. Harris JB, Monir RL, Schoch JJ. Chlorhexidine gluconate for antisepsis in preterm neonates: A review of safety and efficacy. Pediatr Dermatol. 2024;41(5):786–792. https://doi.org/10.1111/pde.15709.

18. Shalepo KV, Spasibova EV, Budilovskaya OV, Krysanova AA, Khusnutdinova TA, Cheberya AS et al. Evaluation of the in vitro effectiveness of the Depantol components on biofilms produced by vaginal microorganisms. Akusherstvo i Ginekologiya (Russian Federation). 2024;(10):158–166. (In Russ.) https://doi.org/10.18565/aig.2024.256.

19. Nazarova NM, Nekrasova ME, Dovletkhanova ER, Abakarova PR. Vaginitis and cervicitis: choice of an effective therapy method (literature review). Meditsinskiy Sovet. 2020;(3):17–23. (In Russ.) https://doi.org/10.21518/2079-701X-2020-3-17-23.

20. Radzinskiy VE, Khamoshina MB, Orazov MR, Tulupova MS, Pestrikova TYu, Yarmolinskaya MI, Rymashevsky AN. Results of a multicenter observational study: therapy for acute non-specific and mixed vaginitis in reproductiveaged patients. Akusherstvo i Ginekologiya (Russian Federation). 2019;(8):150–158. (In Russ.) https://doi.org/10.18565/aig.2019.8.150-158.

21. Lapina IA, Dobrokhotova JE, Taranov VV, Chirvon TG. Prevention of dysbiotic and inflammatory diseases of the vagina and vulva after surgical correction of genital prolapse and stress urinary incontinence. Gynecology. 2020;22(6): 111–114. (In Russ.) https://doi.org/10.26442/20795696.2020.6.200547.

22. Daly JO, Frazer M, Cartwright R, Veit-Rubin N, Giles M. The role of microbial colonisation and infection in pelvic floor mesh complications and implications for management: a commentary. BJOG. 2020;127(2):260–263. https://doi.org/10.1111/1471-0528.15965.

23. Barinova EK, Aryutin DG, Ordiyants EG, Ordiyants IM, Zulumyan TN, Kamarova ZN. Mesh-associated complications in gynecology. Akusherstvo i Ginekologiya: Novosti, Mneniya, Obuchenie. 2021;9(3):102–107. (In Russ.) https://doi.org/10.33029/2303-9698-2021-9-3supp1-102-107.

24. Savicheva AM, Spasibova EV, Shalepo KV. Investigation of the susceptibility of clinical microbial isolates from the female urogenital tract to the active ingredients contained in Depanthol. Russian Bulletin of Obstetrician-Gynecologist. 2019;19(1):86–91. (In Russ.) https://doi.org/10.17116/rosakush20191901192.